PARE approach
The biggest fear after regression of a tumor is of its recurrence. A new cancer test can tell whether and when a tumor is recurring after initial treatment.
The test is based on the sample of the original tumor to identify it's cancer gene sequences which are unique. Later blood tests are used to look for that genetic signature and find out if surgeons have successfully removed the entire tumor, or if the cancer has metastasized or whether it is recurring.
The test has been discovered by a team of Johns Hopkins researchers led by Victor E. Velculescu, MD, PhD.
Researchers found that cancer chromosomes were jumbled, so they looked for larger pieces of the DNA in the tumor. Each patient's tumor has nine characteristic rearrangements at the ends of its chromosomes that form the tumor's unique fingerprint. So the team called the tool `PARE' -- personalized analysis of rearranged ends.
"The PARE approach could be used to develop biomarkers for virtually any cancer," Velculescu said.
© 2007 - 2024 NutritionVista.com. All rights reserved. A single copy of these materials may be reprinted for noncommercial personal use only. All articles and content written by the Nutritionvista.com team for NutritionVista.com are the sole property of J.L.S Healthcare Pvt. Ltd. Content may not be copied without express permission to do so. If you want to link back to an article, please ensure a working link to the article title is used and is functioning at all times.